Management of hypertension in patients during percutaneous dialysis access interventions

J Vasc Access. 2017 Sep 11;18(5):363-365. doi: 10.5301/jva.5000779. Epub 2017 Jul 27.

Abstract

Not infrequently, interventionalists are faced with a patient with increased blood pressure who is about to undergo a dialysis access intervention such as tunneled hemodialysis catheter, percutaneous balloon angioplasty, or declotting procedure for a clotted arteriovenous access. This can frequently create a dilemma as functional dialysis access is needed to provide dialysis therapy and delaying treatment could result in a life-threatening situation, particularly in the presence of hyperkalemia. This article investigates hypertension in patients undergoing percutaneous dialysis access interventions and provides guidance to their management.

MeSH terms

  • Angioplasty, Balloon
  • Antihypertensive Agents / adverse effects
  • Blood Pressure* / drug effects
  • Catheter Obstruction*
  • Catheterization, Central Venous* / adverse effects
  • Endovascular Procedures* / adverse effects
  • Endovascular Procedures* / instrumentation
  • Humans
  • Hypertension / complications
  • Hypertension / physiopathology
  • Hypertension / therapy*
  • Kidney Failure, Chronic / diagnosis
  • Kidney Failure, Chronic / etiology
  • Kidney Failure, Chronic / physiopathology
  • Kidney Failure, Chronic / therapy*
  • Renal Dialysis* / adverse effects
  • Stents
  • Thrombectomy
  • Treatment Outcome
  • Upper Extremity Deep Vein Thrombosis / diagnosis
  • Upper Extremity Deep Vein Thrombosis / etiology
  • Upper Extremity Deep Vein Thrombosis / physiopathology
  • Upper Extremity Deep Vein Thrombosis / therapy*

Substances

  • Antihypertensive Agents